Zils, Katja, Klingebiel, Thomas, Behnisch, Wolfgang, Mueller, Hermann L., Schlegel, Paul-Gerhardt, Fruehwald, Michael, Suttorp, Meinolf, Simon, Thorsten, Werner, Mathias and Bielack, Stefan (2015). Osteosarcoma in Patients with Rothmund-Thomson Syndrome. Pediatr. Hematol. Oncol., 32 (1). S. 32 - 41. PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 1521-0669

Full text not available from this repository.

Abstract

Background: Rothmund-Thomson syndrome (RTS) is associated with an increased risk of osteosarcoma, but information about affected patients is limited. Procedure: Seven patients with osteosarcoma, treated in the Cooperative Osteosarcoma Study Group-trials, had a diagnosis of RTS. Their patient-, tumor-and treatment-related variables and outcome were reviewed retrospectively. Results: Median age at diagnosis of osteosarcoma was 13 years (range 7-16), five were female, two male. Tumor involved proximal tibia (n = 4), distal tibia (n = 1), distal fibula (n = 1) and proximal ulna (n = 1). Three patients had metastatic disease at diagnosis. All patients received surgery and chemotherapy. Four of seven patients required dose modifications and three of them terminated treatment prematurely. Complete resection of the primary tumor was achieved in all individuals. Two of three affected patients failed to achieve surgical clearance of their primary metastases and died. The third patient relapsed with multiple metastases and died. Two of four patients with localized disease were alive in first complete remission, a third patient in second complete remission after recurrence and a fourth patient died of acute leukemia, while still in first complete remission of osteosarcoma. Conclusions: Patients with RTS and osteosarcoma may be cured of their cancer with appropriate multimodal therapy. They should be treated like other osteosarcoma patients but preexisting disorders, needs for special support and development of toxicities have to be considered.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Zils, KatjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klingebiel, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Behnisch, WolfgangUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, Hermann L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlegel, Paul-GerhardtUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fruehwald, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Suttorp, MeinolfUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Simon, ThorstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Werner, MathiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bielack, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-413537
DOI: 10.3109/08880018.2014.987939
Journal or Publication Title: Pediatr. Hematol. Oncol.
Volume: 32
Number: 1
Page Range: S. 32 - 41
Date: 2015
Publisher: TAYLOR & FRANCIS INC
Place of Publication: PHILADELPHIA
ISSN: 1521-0669
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
NEOADJUVANT CHEMOTHERAPY; OSTEOGENIC-SARCOMA; RECQL4 MUTATIONS; THERAPY; COSSMultiple languages
Oncology; Hematology; PediatricsMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/41353

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item